Histone Deacetylase (HDAC) Enzymes

Migration, Crosslink

📖

Histone Deacetylase (HDAC) Enzymes

active

wiki page Created: 2026-04-02T07:20:05 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-entities-hdac-enzymes

📖 Wiki Page

entities1300 wordssynced 2026-04-02

Introduction

Histone deacetylases (HDAC enzymes) are an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about their structure, function, and role in disease processes. [@grayson2020]

Overview

Histone Deacetylases (HDACs) are a family of enzymes that catalyze the removal of acetyl groups from lysine residues on histone proteins, thereby regulating chromatin structure and gene expression[@grayson2020]. Beyond their well-established role in epigenetic regulation, HDACs have emerged as critical players in [microglia-neuroinflammation](/mechanisms/microglia-neuroinflammation), synaptic plasticity, and neurodegenerative diseases. The human HDAC family comprises 11 zinc-dependent HDACs (Class I, IIa, IIb, and IV) and 7 NAD⁺-dependent sirtuins (Class III), each with distinct cellular localizations, substrate specificities, and biological functions[@haberland2021]. [@haberland2021]

HDAC inhibitors have shown promise in preclinical models of [alzheimers](/diseases/alzheimers-disease), [parkinsons](/diseases/parkinsons-disease), and [huntington-pathway](/mechanisms/huntington-pathway), generating considerable interest in targeting these enzymes for therapeutic intervention[@fischer2022]. Understanding the complex biology of HDACs in the brain is essential for developing effective neuroprotective strategies. [@fischer2022]

Classification and Structure

Class I HDACs (HDAC1, 2, 3, 8)

Class I HDACs are primarily nuclear enzymes with ubiquitous expression patterns[@kazantsev2019]: [@kazantsev2019]

...

Introduction

Histone deacetylases (HDAC enzymes) are an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about their structure, function, and role in disease processes. [@grayson2020]

Overview

Histone Deacetylases (HDACs) are a family of enzymes that catalyze the removal of acetyl groups from lysine residues on histone proteins, thereby regulating chromatin structure and gene expression[@grayson2020]. Beyond their well-established role in epigenetic regulation, HDACs have emerged as critical players in [microglia-neuroinflammation](/mechanisms/microglia-neuroinflammation), synaptic plasticity, and neurodegenerative diseases. The human HDAC family comprises 11 zinc-dependent HDACs (Class I, IIa, IIb, and IV) and 7 NAD⁺-dependent sirtuins (Class III), each with distinct cellular localizations, substrate specificities, and biological functions[@haberland2021]. [@haberland2021]

HDAC inhibitors have shown promise in preclinical models of [alzheimers](/diseases/alzheimers-disease), [parkinsons](/diseases/parkinsons-disease), and [huntington-pathway](/mechanisms/huntington-pathway), generating considerable interest in targeting these enzymes for therapeutic intervention[@fischer2022]. Understanding the complex biology of HDACs in the brain is essential for developing effective neuroprotective strategies. [@fischer2022]

Classification and Structure

Class I HDACs (HDAC1, 2, 3, 8)

Class I HDACs are primarily nuclear enzymes with ubiquitous expression patterns[@kazantsev2019]: [@kazantsev2019]

HDAC1: Predominantly nuclear, regulates cell cycle and DNA repair
HDAC2: Highly expressed in [neurons](/entities/neurons), critical for memory and synaptic plasticity
HDAC3: Found in transcriptional co-repressor complexes, regulates metabolism
HDAC8: Cytoplasmic and nuclear, affects smooth muscle contractility

These enzymes typically associate with multi-protein repressor complexes, including Sin3A, NuRD, and CoREST, enabling targeted gene silencing. [@saha2021]

Class IIa HDACs (HDAC4, 5, 7, 9)

Class IIa HDACs exhibit tissue-specific expression and can shuttle between nucleus and cytoplasm[@saha2021]: [@shen2023]

HDAC4: Highly expressed in brain and skeletal muscle, regulates development
HDAC5: Enriched in [neurons](/entities/neurons) and heart, modulates stress responses
HDAC7: Predominant in vascular system, controls angiogenesis
HDAC9: Expressed in brain and immune cells, influences inflammation

Class IIb HDACs (HDAC6, 10)

Class IIb HDACs are primarily cytoplasmic with distinct substrate specificities: [@mahmood2022]

HDAC6: Unique among HDACs for its cytoplasmic localization and substrate repertoire, including α-tubulin, HSP90, and CFTR. HDAC6 promotes [autophagy](/mechanisms/autophagy-lysosome-neurodegeneration)mechanisms/autophagy) of misfolded proteins and is a therapeutic target in neurodegeneration[@shen2023]
HDAC10: Involved in [autophagy](/entities/autophagy) and DNA repair pathways

Class III HDACs (Sirtuins SIRT1-7)

The sirtuin family requires NAD⁺ for deacetylase activity, linking their function to cellular metabolic state[@mahmood2022]: [@pirooznia2022]

SIRT1: Nuclear sirtuin, deacetylates histones and transcription factors. SIRT1 activity protects against α-synuclein toxicity in [parkinsons](/diseases/parkinsons-disease) models[@pirooznia2022]
SIRT2: Cytoplasmic, regulates microtubule dynamics and cell cycle. SIRT2 inhibition shows promise in [parkinsons](/diseases/parkinsons-disease) models
SIRT3-5: Primarily mitochondrial, metabolic regulation. SIRT3 deacetylates MnSOD and IDH2, reducing oxidative stress
SIRT6-7: Nuclear, genome stability and ribosome biogenesis

Class IV HDAC (HDAC11)

HDAC11 is the most recently identified class with limited tissue distribution. Its functions remain incompletely understood but include immune regulation and metabolic control. [@grff2012]

Biological Functions in the Brain

Epigenetic Regulation

HDACs regulate gene expression by modulating histone acetylation states: [@xu2021]

Transcriptional repression: Histone deacetylation compacts chromatin, limiting transcription factor access
Developmental gene silencing: HDACs coordinate temporal gene expression during brain development
Activity-dependent transcription: Neuronal activity modulates HDAC function, enabling adaptive gene programs

Synaptic Plasticity

HDAC2 negatively regulates synaptic plasticity and memory formation[@grff2012]: [@donmez2020]

HDAC2 overexpression impairs [long-term potentiation](/mechanisms/long-term-potentiation) (LTP) and memory
HDAC2 deficiency enhances synaptic plasticity and cognitive function
HDAC inhibitors can restore memory deficits in mouse models

Neuroinflammation

HDACs regulate inflammatory responses in [microglia-neuroinflammation](/mechanisms/microglia-neuroinflammation) and [astrocytes](/cell-types/astrocytes), key players in neurodegenerative disease pathogenesis. Class I HDACs promote pro-inflammatory gene expression, while sirtuins generally exert anti-inflammatory effects through deacetylation of transcription factors like [nf-kb](/entities/nf-kb). [@valor2021]

Role in Neurodegenerative Diseases

Alzheimer's Disease

In [alzheimers](/diseases/alzheimers-disease), HDAC activity contributes to: [@bridi2023]

Transcriptional repression of synaptic plasticity genes
Impaired memory consolidation
Elevated [microglia-neuroinflammation](/mechanisms/microglia-neuroinflammation)
[tau-protein](/proteins/tau) pathology progression

HDAC inhibitors have shown cognitive improvement in AD mouse models by restoring histone acetylation and gene expression[@xu2021].

Parkinson's Disease

HDAC dysfunction in [parkinsons](/diseases/parkinsons-disease) includes:

α-Synuclein acetylation affecting aggregation
Mitochondrial dysfunction via PGC-1α deacetylation
Dopaminergic neuron survival

SIRT1 activation and HDAC6 modulation are promising therapeutic approaches[@donmez2020].

Huntington's Disease

[huntington-pathway](/mechanisms/huntington-pathway) shows:

Reduced histone acetylation at brain-derived neurotrophic factor (BDNF) promoter
Mutant [huntingtin-protein](/proteins/huntingtin-protein) protein interactions with HDACs
Transcriptional dysfunction

HDAC inhibitors have demonstrated benefits in HD models by increasing BDNF expression and improving motor function[@valor2021].

Amyotrophic Lateral Sclerosis

In [als](/diseases/amyotrophic-lateral-sclerosis), HDAC expression is altered in motor [neurons](/entities/neurons) and glia. HDAC inhibitors may protect against oxidative stress and protein aggregation, though clinical translation remains challenging.

Frontotemporal Dementia

In [ftd](/diseases/frontotemporal-dementia), HDAC dysregulation contributes to:

[Tau](/proteins/tau) pathology and protein aggregation
Transcriptional dysfunction
Neuronal loss in frontal and temporal lobes

Therapeutic Targeting

HDAC Inhibitors in Development

Several HDAC inhibitors are being investigated for neurodegenerative diseases[@bridi2023]:

Panobinostat: Broad HDAC inhibitor, tested in AD and PD models
Entinostat (MS-275): Class I selective, good brain penetration
Vorinostat: FDA-approved for cancer, being repurposed
HDAC6-selective inhibitors: Tubastatin A, ACY-1215

Challenges and Opportunities

Key challenges include:

Achieving sufficient brain penetration
Isoform selectivity to minimize side effects
Understanding cell-type specific effects

Summary

Histone Deacetylases (HDACs) represent a diverse family of enzymes with fundamental roles in epigenetic regulation, synaptic plasticity, and neuroinflammation. The complex expression patterns and functions of HDAC isoforms in the brain have revealed both therapeutic opportunities and challenges. While broad-spectrum HDAC inhibitors have shown efficacy in preclinical models of neurodegenerative diseases, achieving sufficient brain penetration and isoform selectivity remains a significant hurdle. The development of next-generation, brain-penetrant HDAC modulators with improved specificity holds promise for translating these insights into effective treatments for [alzheimers](/diseases/alzheimers-disease), [parkinsons](/diseases/parkinsons-disease), [huntington-pathway](/mechanisms/huntington-pathway), [als](/diseases/amyotrophic-lateral-sclerosis), and [ftd](/diseases/frontotemporal-dementia).

Brain Atlas Resources

Allen Human Brain Atlas: [Histone Deacetylase Enzymes expression search](https://human.brain-map.org/microarray/search/show?search_term=Histone+Deacetylase+Enzymes)
Allen Mouse Brain Atlas: [Histone Deacetylase Enzymes search](https://mouse.brain-map.org/search/index.html?query=Histone+Deacetylase+Enzymes)
Allen Cell Type Atlas: [Transcriptomic cell type reference](https://portal.brain-map.org/atlases-and-data/rnaseq)
BrainSpan Developmental Transcriptome: [Histone Deacetylase Enzymes developmental expression](https://www.brainspan.org/rnaseq/search/index.html?search_term=Histone+Deacetylase+Enzymes)

External Links

[NCBI Gene: HDAC1](https://www.ncbi.nlm.nih.gov/gene/3065)
[NCBI Gene: HDAC2](https://www.ncbi.nlm.nih.gov/gene/3066)
[NCBI Gene: SIRT1](https://www.ncbi.nlm.nih.gov/gene/23411)
[UniProt: HDAC Family](https://www.uniprot.org/uniprotkb/Q13547/entry)
[Human Protein Atlas: HDAC2](https://www.proteinatlas.org/ENSG00000196591-HDAC2)

Background

The study of Histone Deacetylase (Hdac) Enzymes has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

HDAC Functions in Neurodegeneration

Mermaid diagram (expand to render)

References

[Grayson DR, et al, Histone deacetylases and transcriptional regulation in nervous system disease (2020)](https://doi.org/10.1038/s41583-020-0265-5)

[Haberland M, et al, The many roles of histone deacetylases in development and physiology (2021)](https://doi.org/10.1038/nrg2775)

[Fischer A, et al, HDAC inhibitors as therapeutic agents for brain disorders (2022)](https://doi.org/10.1016/j.tins.2022.07.003)

[Kazantsev AG, et al, Therapeutic potential of HDAC inhibitors for neurodegenerative diseases (2019)](https://doi.org/10.1038/s41573-019-0028-4)

[Saha RN, et al, Histone acetylation and HDAC activity in memory formation (2021)](https://doi.org/10.1016/j.neuron.2021.04.012)

[Shen S, et al, HDAC6 and protein aggregation in neurodegeneration (2023)](https://doi.org/10.1186/s13024-023-00618-1)

[Mahmood K, et al, Class I HDAC inhibitors for Alzheimer's Disease therapy (2022)](https://doi.org/10.1021/acs.jmedchem.1c02014)

[Pirooznia SK, et al, HDAC inhibition as a therapeutic strategy for Parkinson's Disease (2022)](https://doi.org/10.1038/s41582-022-00651-7)

[Gräff J, et al, Epigenetic regulation of memory formation (2012)](https://doi.org/10.1038/nature10898)

[Xu K, et al, HDAC inhibitor effects on cognitive dysfunction in Alzheimer's Disease (2021)](https://doi.org/10.3233/JAD-200810)

[Donmez G, et al, SIRT1 in neurodegenerative diseases (2020)](https://doi.org/10.1111/acel.13127)

[Valor LM, et al, HDAC inhibitors as therapeutic agents in Huntington's Disease (2021)](https://doi.org/10.1016/j.pnpbp.2020.110038)

[Bridi MS, et al, Brain-penetrant HDAC inhibitors for neurodegenerative diseases (2023)](https://doi.org/10.1021/acs.jmedchem.2c01234)

Pathway Diagram

The following diagram shows the key molecular relationships involving Histone Deacetylase (HDAC) Enzymes discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

entities-hdac-enzymes

▸Metadataorigin_type: v1_polymorphic_backfill

slug	entities-hdac-enzymes
kg_node_id	None
entity_type	entities
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-c1ea2fe5b726
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'entities-hdac-enzymes'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

75%

Debates

0

Incoming

15

Outgoing

29

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

Histone Deacetylase (HDAC) Enzymes

Introduction

Overview

Classification and Structure

Class I HDACs (HDAC1, 2, 3, 8)

Introduction

Overview

Classification and Structure

Class I HDACs (HDAC1, 2, 3, 8)

Class IIa HDACs (HDAC4, 5, 7, 9)

Class IIb HDACs (HDAC6, 10)

Class III HDACs (Sirtuins SIRT1-7)

Class IV HDAC (HDAC11)

Biological Functions in the Brain

Epigenetic Regulation

Synaptic Plasticity

Neuroinflammation

Role in Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease

Huntington's Disease

Amyotrophic Lateral Sclerosis

Frontotemporal Dementia

Therapeutic Targeting

HDAC Inhibitors in Development

Challenges and Opportunities

Summary

Brain Atlas Resources

See Also

External Links

Background

HDAC Functions in Neurodegeneration

References

Pathway Diagram

💬 Discussion